Omega Healthcare price target raised to $32 from $31 at Truist

Truist raised the firm’s price target on Omega Healthcare to $32 from $31 and keeps a Hold rating on the shares. The firm is adjusting its FFO estimates to reflect more conservative timing on the Guardian restructuring and Maplewood return to full contractual rent, though it is also “encouraged” by improving occupancy and rent coverage, the analyst tells investors in a research note, adding that the company has a healthy balance sheet and access to capital to facilitate new investments.